Diabetes Firm CeQur Gains J&J's Calibra Wearable Insulin Patch

With Johnson & Johnson bowing out of the diabetes device market, US firm CeQur has benefited from by securing assets from the health-care giant's Calibra Medical insulin delivery device business.

With Johnson & Johnson bowing out of the diabetes device market, US firm CeQur has benefited from this exit by securing assets from the health-care giant's Calibra Medical insulin delivery device business.

CeQur, a 10-year old company, has acquired selected assets of J&J's Calibra's OneTouch Via product – a three-day, wearable, on-demand...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business